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Abstract 
 
Ruminants are important reservoirs of E. coli O157:H7 and are considered as the 
major source of the most foodborne outbreaks (e.g. 2017 outbreak in Germany, 2014 
and 2016 outbreaks in U.S.A., all linked to beef products). A promising strategy to 
reduce E. coli O157 is using antimicrobials to reduce the pathogen levels and/or 
virulence within the animal gastrointestinal tract and thus foodborne disease. The aim 
of the study was to determine the efficacy of a commercial mixture of natural 
antimicrobials against E. coli O157. The minimum inhibitory concentration and 
minimum bactericidal concentration of the antimicrobial were quantitatively 
determined and found to be 0.5 and 0.75% (v/v) of the natural antimicrobial, 
respectively. Microbial growth kinetics were also employed to determine the effect of 
the antimicrobial on the pathogen. The natural antimicrobial affected the cell 
membrane of E. coli O157, as demonstrated by the increase in relative electric 
conductivity and increase in protein and nucleic acid release. The antimicrobial was 
also able to significantly reduce the concentration on E. coli O157 in a model rumen 
system. Biofilm assays showed that sub-inhibitory concentrations of the antimicrobial 
significantly reduced the E. coli 0157 biofilm forming capacity without influencing 
pathogen growth. Also, the natural antimicrobial was able to reduce motility and 
exopolysaccharide production. Sub-inhibitory concentrations of the antimicrobial had 
no effect on AI-2 production. These findings suggest that the natural antimicrobial 
exerts an antimicrobial effect against E. coli O157 in vitro and in a model rumen system 
and could be potentially used to control this pathogen in the animal gut. The results 
also indicate that sub-inhibitory concentrations of the antimicrobial effectively reduce 
biofilm formation, motility and exopolysaccharide production.  
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Introduction 
 
Escherichia coli O157:H7 is an important foodborne pathogen that has been linked to 
many outbreaks worldwide. Shiga toxins are major virulence factors of this pathogen 
and their production in the human gut along with other virulence factors can cause 
clinical manifestations that range in severity, even leading to life threatening hemolytic 
uremic syndrome (Luck et al. 2005; Smith et al. 2014). Ruminants, in particular cattle, 
are considered an important source of E. coli O157:H7 most frequently colonising the 
lower gastrointestinal tract of cattle (Xu et al. 2014). Quantitative risk assessments 
have brought to light the association between levels of E. coli O157:H7 in faeces and 
hides of cattle and the contamination of beef carcasses (Duffy et al. 2006). Treating 
patients with E. coli O157 infection is problematic since many antibiotics are shown to 
enhance shiga toxin production in vitro and in vivo and thus increase the risk of 
hemolytic uremic syndrome development (Zhang et al. 2000). Owing to the potentially 
severe public health concerns, both researchers and industry are continuously 
investigating different strategies to control this pathogen. Different studies have sought 
to identify effective ways of reducing foodborne pathogens at pre-harvest and post-
harvest stages including plant derived compounds, bacteriophages, vaccines and 
antimicrobial peptides (McDonnell et al. 2012; Shi et al. 2017; Zhang et al. 2000). 
However, the frequent foodborne disease outbreaks linked to meat and meat products 
demands further research. E. coli O157 cells are able to form complex aggregations 
which are enclosed in a matrix of exopolysaccharides (EPS) called biofilms. EPS plays 
a key role in the biofilm architecture and provides increased resistance to different 
types of stresses (e.g. host immune responses, osmotic and oxidative stresses 
antimicrobial agents) (Hentzer et al. 2003; Rivas et al. 2010; Silva et al. 2014).  
Quorum sensing (QS) constitutes a global regulatory mechanism for different 
physiological functions of E. coli as well as for virulence factors including biofilm 
formation (Sperandio et al. 2001). These virulence characteristics pose a significant 
challenge in clinical, veterinary and industry settings and identifying ways of controlling 
them are of great importance. It has been found that different natural plant extracts 
and compounds (e.g. carvacrol, brazilin) although they can be bactericidal, in sub-
lethal concentrations can potentially increase the phenotypic expression of virulence 
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and virulence gene expression of pathogenic E. coli (García-Heredia et al. 2016). 
Therefore, in addition to determining the bactericidal effect of different antimicrobial 
agents, it is also important to determine the effect of varying concentrations of these 
agents on virulence expression since these pathogens can be transferred, during the 
slaughter processs, from the animal gut to meat processing surfaces and meat, 
ultimately reaching the consumer. 
There are no reliable commercially available strategies to control the carriage of E. 
coli O157 in ruminants (Rivas et al. 2010).   
 
The objectives of this pilot study were to determine the antimicrobial effect of a 
commercial mixture of natural antimicrobials  against different strains of E. coli 
O157:H7. Also, to investigate its antimicrobial mechanism and also to determine its 
effect on motility, biofilm formation, exopolysaccharide production and quorum 
sensing at sub-inhibitory concentrations.  
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Materials and Methods 
 
Bacterial strains and antimicrobial 
E. coli O157:H7 EDL 933 (ATCC 43895), E. coli O157 VSD 400 and E. coli O157 PHL 
09 were maintained in Tryptone Soya Agar plus 0.6% yeast extract (TSAYE, Oxoid, 
UK) slopes at 4°C. When necessary the pathogens were cultured in Mueller-Hinton 
broth (MHB) at 37 °C for 24 h. The antimicrobial product Auranta 3009 was obtained 
from Envirotech Innovative Products Ltd and consisted of lactic acid, E330 citric acid 
and citrus extract. The manufacturer of this product is Bio Science Nutrition Ireland 
Ltd, Ireland, DAFM No.IELK241361.  
 
Growth curves 
The three individual E. coli O157 culture (6.0 log CFU/ml in MHB) were transferred 
into 96 well microtiter plates with final concentrations of the natural antimicrobial of 
0, 0.0625, 0.125, 0.25, 0.5 and 0.75% (v/v). The inoculum level was determined 
after plating out onto MHA plates and incubation at 37 °C for 24 h. Cultures were 
incubated at 37°C, and optical density was monitored at 600 nm at intervals of 1 hour, 
over 24 h, using an automatic plate reader (FLUOstar Omega, BMG Labtech, U.K.). 
The concentrations of the antimicrobial that did not inhibit bacterial growth were 
chosen as the sub-inhibitory concentrations and used for the subsequent phenotypic 
virulence assays. 
 
 
Minimum inhibitory concentration (MIC) and Minimum bactericidal 
concentrations (MBC) 
In order to determine MIC and MBC we have used a methodology as previously 
described by Zhu et al. (2016). Briefly, the antimicrobial was diluted from 8% to 0.015% 
(v/v) in MHB. An overnight bacterial culture was diluted to approximately 6 
Log CFU/mL in MHB. A tube containing each dilution of the natural antimicrobial in 
MHB was inoculated with 5.49 ± 0.16 log CFU/ml  of bacterial culture. Non-inoculated 
tubes were used as positive controls. Subsequently, the tubes were incubated at 37°C 
for 24 h. The highest dilution of the natural antimicrobial in the tube without visible 
bacterial growth was considered as the MIC. To determine the MBC, 100 µl of the 
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cultures that showed no growth were spread plated onto Mueller-Hinton Agar (MHA) 
plates and incubated at 37 °C for 24 h.  
 
Cell membrane permeability 
E. coli O157:H7 cell membrane permeability was determined by assessing the electric 
conductivity of  cultures treated with different concentrations of the natural 
antimicrobial for 2, 6  and 24 h, as described by Stratakos et al. (2018). A conductivity 
meter (Jenway 4200, U.K.) was used to quantify changes in electric conductivity. 
Bacteria were washed with 5% glucose until their electric conductivity was near to that 
of 5% glucose (isotonic bacteria). The antimicrobial was added to 5% glucose (0, MIC, 
MBC) and the electric conductivities were measured (L1). The same concentrations of 
the antimicrobial were also prepared with the isotonic bacteria and the conductivities 
were measured after 2, 6 and 24 h incubation at 37 °C (L2). The conductivity of 
bacteria cells in 5% glucose treated in boiling water for 5 min was used (L0) as control. 
The permeability of cell membrane was calculated using the equation: Relative electric 
conductivity (%) = 100 (L2 – L1)/L0. 
  
Membrane integrity 
Membrane integrity for the three E. coli strains was evaluated in terms of protein 
leakage and 260 nm absorbing materials into the cell suspension as previously 
described (Stratakos et al. 2018), after a 6 h treatment with different concentrations of 
natural antimicrobial (0, MIC and MBC). The protein content in the supernatants was 
assessed using the Pierce BCA protein kit (ThermoScientific, U.K). Nucleic acid 
leakage in terms of optical density of 260 nm absorbing materials was performed using 
a UV-vis spectrophotometer (FLUOstar Omega, BMG Labtech, U.K.). Untreated 
samples were used as controls. 
 
In vitro rumen assay 
The antimicrobial efficiency of the natural antimicrobial (0, MIC, MBC and 2xMBC) 
against E. coli O157 EDL 933 was tested in the assay. Three dairy cows (Swedish-
Red × Jersey/Holstein-Friesian) fitted with rumen cannula were used as rumen fluid 
donors. The rumen fluid was collected 3 h after the morning feeding. At the laboratory, 
the rumen contents (solid and liquid phases) were homogenised, filtered through four 
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layers of cheesecloth and maintained at 39°C under anaerobic conditions. The filtered 
rumen fluid was dispensed into bottles and diluted with four parts of a buffer solution. 
The buffer solution was prepared by combining two solutions: buffer A and buffer B 
(5:1). The following quantities were used to prepare one litre of buffer A: 10 g KH2PO4; 
0.5 g MgSO4.7H2O; 0.5 g NaCl; 0.1 g CaCl2.2H2O and 0.5 g Urea. One litre of buffer 
B was prepared using the following: 15 g Na2CO3 and 1 g Na2S.9H2O. After mixing at 
39oC, the combined buffer solution was adjusted to a final pH of 6.8. An overnight 
culture of E. coli O157 was prepared and serially diluted in 9 ml of PBS and inoculated 
into the rumen at approximately 6 Log CFU/ml. All bottles were flushed with CO2 for 
approximately 1 min prior to incubation at 39°C, with agitation. Samples were taken 
from each bottle at 0, 4, 18 and 24 h. After sampling at each time point, all bottles were 
flushed with CO2 for approximately 1 min before reincubation at 39°C. For spread 
plating, 1 ml aliquots taken from each bottle were serially diluted in 9 ml volumes of 
MRD and 0.1 ml aliquots of each dilution were spread onto plates of TSA which were 
incubated at 37°C for 2 h. Subsequently, they were overpoured with CT-SMAC and 
incubated for another 48 h to allow for the recovery of injured cells. The suspected E. 
coli O157 positive colonies were confirmed by latex agglutination (Prolex™ E. coli 
O157 Latex test reagent kit, Prolab Diagnostics, U.K.). Treatments and control 
samples (without antimicrobial addition) were incubated in triplicate. The assay was 
performed in duplicate, using fresh rumen fluid on two separate days. 
 
Biofilm formation and motility assay 
A biofilm formation assay for E. coli EDL 933 was performed in 96-well polystyrene 
plates according to the method described by Lee et al. (2014). Briefly, overnight 
cultures were inoculated into Luria-Bertani (LB) broth (Oxoid, U.K.) with known 
concentrations (0, 0.0625 and 0.125%) of the antimicrobial and cultured for 24 h 
without shaking at 37°C. To quantify biofilm formation, wells were washed three times 
with PBS to remove all non-adherent cells. Cells were fixed with 200 µl of methanol 
for 20 min. Biofilms were stained with crystal violet (0.4% w.v) for 15 min and washed 
three times with PBS. The formed biofilm was then dissolved with 200 µl 96% ethanol 
for 30 min and absorbance was measured (570 nm) in a microtiter plate reader. 
Cultures with no added antimicrobial served as positive controls. Motility was 
determined as described by Kulshreshtha et al. (2016). Briefly five microliters of E. 
coli O157 culture (~7.0 log CFU) were stabbed into plates with semisolid medium 
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(MHB supplemented with 0.5% agar) with and without 0.0625 and 0.125% of the 
natural antimicrobial. Plates with no added antimicrobial served as positive controls. 
Exopolysaccharide (EPS) content determination 
An E. coli O157 EDL 933 culture grown in the presence and absence of sub-MIC of 
the antimicrobial was centrifuged and the supernatant was filtered through a 0.22 µm 
filter. Three volumes of chilled 100% ethanol were added to the filtered supernatant 
and incubated overnight at 2°C to precipitate the EPS. The ethanol wash and 
centrifugation steps were repeated three times (Al-Shabib et al. 2016; Huston et al. 
2004). EPS was quantified using the colorimetric phenol-sulphuric acid method as 
previously described (DuBois et al. 1956) 
 
Autoinducer-2 (AI-2) assay 
To determine whether AI-2 production in the E. coli O157 EDL 933 is affected by sub-
inhibitory concentrations of the novel antimicrobial, the autoinducer-2 (AI-2) assay was 
performed as previously described (Castillo et al. 2015; Duan and March 2010). 
Briefly, approximately 7 Log CFU/mL of E. coli O157 were inoculated and cultured in 
LB broth with 0.5% (w/v) glucose containing 0, 0.0625 and 0.125% of the antimicrobial 
at 37°C for 6 h. Vibrio harveyi BB170 was grown overnight at 30°C with agitation in 
Autoinducer Bioassay medium (AB) and diluted 1∶3,000. Cultures to be tested for CAI-
1 activity were centrifuged (12,000 × g for 5 min). The supernatant was filtered and 
20 μL of cell-free supernatant was added to 80 μL of diluted V. harveyi BB 
170 reporter culture in a sterile 96-well plate and incubated at 30°C with shaking at 
500 rpm. The luminescence values of the samples were measured in an automatic 
plate reader (FLUOstar Omega, BMG Labtech, U.K.) every 0.5 h. The analysis was 
repeated three times. In addition the E. coli cultures were enumerated by plating on 
brain-heart infusion agar. The aforementioned concentrations of the antimicrobial 
were also tested against growth of V. harveyi BB170 to ensure that decrease in 
bioluminescence was not caused by growth inhibition. 
 
 
 
 
 
Statistical analysis 
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All experiments were performed in triplicate. To measure the statistical significance 
we used two tailed Student’s t test. A group difference was assumed to be statistically 
significant when P < 0.05. All results were expressed as means ± S.D. 
 
 
Results 
Antimicrobial activity and mechanism 
The antimicrobial exerted a potent effect against all E. coli O157 strains tested, with 
MIC and MBC values of 0.5 and 0.75% (v/v) of the natural antimicrobial.  The 
antimicrobial activity can be attributed to the lactic acid, citric acid and citrus extract 
present in the antimicrobial solution. The results revealed (Fig 1) that the electric 
conductivity of all treated samples increased significantly (P < 0.05) with exposure 
time (2 to 24 h) and with increasing concentrations of the antimicrobial (P < 0.05). 
These results indicate that the gradual increase in cell membrane permeability leads 
to cellular leakage. Membrane integrity was also studied by monitoring protein (Fig. 
2A) and nucleic acids release (Fig 2B) in terms of 260 nm absorbing materials. When 
the antimicrobial was applied at MIC and MBC levels, protein release was found to 
progressively increase with time (P < 0.05). Also, when the antimicrobial was applied 
at the MBC level, protein release was significantly higher compared to the MIC treated 
E. coli O157. A very similar trend was observed for nucleic acid release (OD260nm). 
Application of the natural antimicrobial at MIC and MBC concentrations resulted in 5-
12 fold increase in 260 nm materials release (P < 0.05) after 24 h. There was also a 
gradual increase in the 260 nm materials release during the 24h incubation, with the 
release of MBC treated cells being always higher compared to the MIC treatment 
(P < 0.05). Protein and nucleic acid release for control samples remained stable in all 
cases. The above results suggest that membrane structural damage is taking place at 
both MIC and MBC concentrations for all three E. coli O157 strains tested. Since the 
three strains had the same MIC and MBC values and exhibited similar behaviour in 
terms of cell membrane integrity and permeability only E. coli EDL 933 was used in 
subsequent experiments as it is widely used in other studies thus allowing better 
comparisons. 
 
 
Growth curves 
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Growth curves revealed complete inhibition of growth at MBC and MIC, as expected. 
The 1/2 MIC (0.25% v/v) concentrations caused a prolongation of the lag phase of all 
three E. coli O157 strains tested for 1 hour whereas 1/4 MIC (0.125% v/v) and 1/8 MIC 
(0.625% v/v)  showed a very similar growth curve to the control showing that theses 
concentrations had no effect on growth (Fig 3). Therefore these two concentrations 
were selected to study the effect on motility, biofilm formation, exopolysaccharide 
production and quorum sensing. 
 
In vitro rumen system 
Application of the antimicrobial at the MIC level did not influence the growth of the 
pathogen, which was very similar to the control (P > 0.05). Application at the MBC 
level resulted in a gradual reduction in the E. coli O157 counts, with the levels of the 
pathogen being significantly lower (5.15 ± 0.38 log CFU/ml) compared to the control 
and MIC treatment after 18 h of incubation (Fig 4). After 24h, the pathogen levels were 
reduced by 1.63 log CFU/ml for the MBC treatment. The 2xMBC reduced the levels 
of E. coli O157 by approx. 1 log CFU/ml within 4h, compared to the control and MIC 
treatments (P < 0.05). The pathogen levels were reduced by 3.15 log CFU/ml after 
24h, which was significantly lower compared to the pathogen levels at 24h for the MBC 
treatment (P < 0.05). 
 
Effect on biofilm and motility  
Addition of the natural antimicrobial at sub-inhibitory levels significantly decreased 
(P<0.05) biofilm formation by E. coli O157, in a dose dependent manner by 43.20 
and 52.13 % compared to the control (Fig 5). The effect of the novel antimicrobial 
on the pathogen motility is shown in figure 6. The natural antimicrobial at both sub-
inhibitory concentrations resulted in a clear reduction in the motility of the pathogen 
(34.11 ± 3.95mm) compared to 68.77 ± 5.50mm for the control (P < 0.05). 
 
Effect on EPS production 
Spectrophotometric determination of the extracted EPS revealed that the 
concentration of EPS decreased when the antimicrobial was applied (Figure 7). A 
statistically significant reduction in the EPS production was recorded at both sub-
inhibitory concentrations tested. The natural antimicrobial treated samples showed 
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a 48.17 ± 5.67 and 52.07 ± 11.50% reduction in EPS production. However, no 
difference was found between the two treatments (P < 0.05).  
 
Effect on Quorum sensing  
The effect of the natural antimicrobial on AI-2 production by E. coli O157:H7 was 
assayed using the V. harveyi BB170 reporter strain. The reporter strain is 
bioluminescent in response to the presence of AI-2. Results showed that a six-hour 
treatment of E. coli O157:H7 with sub-inhibitory concentrations of the antimicrobial did 
not result in any significant changes (P < 0.05) in AI-2 production compared to the 
control (Fig. 8A). The antimicrobial at the concentrations used (0.0625 and 0.125%) 
did not have any effect on the growth of E. coli O157 (Fig. 8B). Also, the antimicrobial 
showed no antimicrobial activity against V. harveyi at the concentrations used in this 
study (results not shown). 
 
Discussion 
Enterohemorrhagic E. coli O157:H7 infection is a worldwide problem linked to many 
foodborne outbreaks (Vygen-Bonnet et al. 2017; CDC 2018). Since ruminants are an 
important source of this pathogen (EFSA 2010), reducing its ability to reside in the 
animal gastrointestinal tract would be desirable. In the present study we demonstrated 
that the natural antimicrobial is effective against E. coli O157:H7 with MIC and MBC 
values of 0.5 and 0.75% (v/v), respectively.  
When bacteria are exposed to antimicrobial agents, different physical changes occur 
to their cell membranes (Bajpai et al. 2013). We show that the bactericidal effect 
observed is linked to the ability of the antimicrobial to disrupt E. coli O157:H7 
membranes as described in figure 1. This indicates a potential leakage of ions even 
at the MIC level because the bacterial membrane acts as a barrier to the movement 
of electrolytes that take part in cell functions and metabolism (Diao et al. 2014). 
Different studies have investigated the effect of plant extracts on E. coli O157. 
Exposing E. coli O157 to eugenol has also been observed to cause membrane 
damage and subsequent leakage of intracellular components (Di Pasqua et al. 2007).  
Commercial citrus fruit extracts have also been found to cause physical damage to 
Salmonella enterica and E. coli membranes and leakage of cellular materials (Alvarez-
Ordonez et al. 2013). 
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Stratakos et al. (2018) also found that carvacrol was able to increase cell membrane 
permeability in different STEC strains leading to cell death. Release of proteins and 
nucleic acids (260 nm absorbing materials) is used as an indirect way to assess 
membrane damage after application of an antimicrobial treatment (Bajpai et al. 2013; 
Stratakos et al. 2018). The natural antimicrobial caused a rapid release of proteins 
and 260 nm absorbing material, which increased over time, suggesting damage to the 
cytoplasmic membrane of the pathogen, which is consistent with the increase in 
relative electric conductivity. Zhang et al. (2017) also observed a dose dependent 
increase (0, MIC, 2xMIC) in the protein and nucleic acid release of non-pathogenic E. 
coli cells after treatment with black pepper essential oil. Carvacrol and cinnamon 
essential oil has also been found to cause protein and nucleic acid release in E. coli 
and Staphylococcus aureus (Zhang et al. 2016). In general, the novel antimicrobial 
was found to interfere with E. coli O157 ion homeostasis and membrane integrity.  
The in vitro rumen model showed that it is possible to reduce E. coli O157 EDL 933 
shedding in ruminants with the natural antimicrobial. The 2xMBC was used in the 
experimental design as it has been found in other studies that antimicrobials exhibit 
significantly reduced activity when applied in complex systems since these systems 
can contain different inhibitors (Burt 2004; Rydlo et al. 2006). McDonnell et al. (2012) 
found that although caseicin A was able to reduce E. coli O157 in a broth system the 
same concentrations (≥ 2 mg/ml) had no effect when applied in an in vitro model 
system. The study of Rivas et al. (2010) showed that carvacrol applied at a 
concentration of 1000 μg/ml reduced E. coli O157 by > 5 log CFU/ml in an in vitro 
rumen system after 24 h incubation. However, more work is required to elucidate 
further the effects of the antimicrobial on rumen microbiota and thus rumen 
fermentation. 
It is possible that during ingestion of an antimicrobial present in the feed or water, its 
concentrations can be reduced due to partial inactivation when coming in contact with 
other compounds in the animal digestive system or simply by dilution. These lower 
concentrations might not have an effect on growth of pathogens residing in the gut but 
can potentially have an effect on different virulence factors (García-Heredia et al. 
2016). Although a potential increase in the virulence of the pathogen due to exposure 
to sub-inhibitory concentrations of the antimicrobial will not cause any clinical 
symptoms to the animal, it could potentially result in cells with increased virulence 
being transferred to the meat or food producing surfaces during the slaughter process, 
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increasing the risk and/or severity of human infection. Therefore, the present study 
also investigated the effect of sub-inhibitory concentrations of the antimicrobial on 
different virulence factors of E. coli O157:H7.  
 
E. coli O157 is also able to form biofilms on various biotic and abiotic surfaces. These 
biofilms are resistant to host immune responses, antimicrobial agents and other 
stresses (Kim et al. 2016). Therefore, sub-inhibitory concentrations of the natural 
antimicrobial were used to investigate the effect on biofilm formation. Both 
concentrations used (0.0625 and 0.152%) reduced E. coli O157 biofilm formation in a 
dose dependent manner without affecting the growth of planktonic cells (Fig. 5) 
Previously, eugenol was found to inhibit biofilm formation by Listeria monocytogenes 
and E. coli O157 (Perez-Conesa et al. 2006; Upadhyay et al. 2013). Similarly, sub-
inhibitory concentrations of citral have been found to inhibit Cronobacter 
sakazakii biofilm formation at 12°C and 25°C (Shi et al. 2017). Carvacrol has also been 
found to inhibit biofilm formation in Campylobacter jejuni (Burt et al. 2014).  
Motility plays an important role in E. coli biofilm formation (Ren et al. 2001) and also 
contributes to colonisation of host tissues and enables pathogens to move towards 
favourable environments and away from repellents (Zhu et al. 2015). Therefore, the 
motility of E. coli O157:H7 during exposure to sub-inhibitory concentrations of the 
antimicrobial was also investigated. Both sub-inhibitory concentrations of the 
antimicrobial significantly reduced the motility of the pathogen (Fig. 6). The presence 
of functioning flagella is required for motility and biofilm formation in Gram-negative 
bacteria (Chelvam et al. 2014). Burt et al. (2016) showed that organic acids, 
specifically cinnamic (0.2%), lactic (0.6%) and propionic acid (0.4%) can reduce 
motility in Salmonella typhimurium. Mith et al. (2015) also found that oregano essential 
oil and carvacrol are able to significantly down-regulate genes involved in motility of 
E. coli O157:H7. Carvacrol has also been found, after overnight incubation, to prevent 
the development of flagella in E. coli O157:H7 leading to aflagellate and non-motile 
cells. Coumarins were also found to supress curli genes and motility genes by causing 
reductions in fimbriae production and swarming motility in E. coli O157:H7 (Lee et al. 
2014). Thus, a possible explanation for the reduced motility observed is inhibition of 
the flagellar synthesis by the sub-inhibitory concentrations of the antimicrobial. 
To further elucidate the effect on E. coli O157:H7 virulence, EPS production by treated 
and non-treated bacteria was determined. E. coli O157:H7 produces EPS which acts 
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as a physical barrier to protect cells against different stresses. EPS is also involved in 
cell adhesion and the formation of three-dimensional biofilm structures (Ryu and 
Beuchat 2005). Therefore, any changes in the EPS production by the pathogen can 
have an effect on biofilm formation and architecture and also reduce resistance to 
drugs. In this study our results revealed that EPS was reduced significantly and to 
the same extent by the two sub-inhibitory concentrations of the antimicrobial (Fig. 
7). The study of Al-Shabib et al. (2016) also showed that EPS was reduced 
significantly when Listeria monocytogenes and E. coli were treated with sub-
inhibitory concentrations of zinc oxide nanostructures from Nigella sativa. Cellulose 
is one of the EPS components that enable biofilm formation in Enterobacteriaceae 
(Priester et al. 2006). Shi et al. (2017) found that treating Cronobacter sakazakii cells 
with citral down-regulated the expression of bcsA and bcsG that encode the cellulose 
biosynthesis operon. In the present study, we hypothesise that the novel 
antimicrobial could potentially affect the synthesis of components (e.g. cellulose) 
which EPS consists of and thus lead to inhibition of E. coli O157:H7 biofilm formation. 
 
Accordingly our results showed that sub-inhibitory concentrations of the novel 
antimicrobial can reduce the pathogen’s biofilm forming capability, motility and 
exopolysaccharide production. The data also suggest that the antimicrobial does not 
interfere with the AI-2 synthetic pathway and thus the anti-biofilm effect of the 
antimicrobial is not closely linked to AI-2 production. 
 
Conclusion 
Our study showed that the natural antimicrobial has a potent antimicrobial effect 
against all tested E. coli O157:H7 strains and exerts its antimicrobial effect by cell 
membrane disruption. Our data also shows that the antimicrobial can reduce the levels 
of the pathogen in an in vitro rumen model and revealed that sub-inhibitory 
concentrations of the antimicrobial attenuate E. coli O157:H7  reduced biofilm 
formation, motility and exopolysaccharide production, potentially reducing the risk and 
severity of disease. However, expression of virulence could be influenced by other 
factors during the slaughter process which should be also investigated in the future. 
Future studies should also elucidate the effect of the antimicrobial on Shiga toxin 
production as it is one of the main E. coli O157:H7 virulence factors. These findings 
indicate that the natural antimicrobial can potentially be used as an antimicrobial to 
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reduce the presence of E. coli O157:H7 in the gastrointestinal tract of ruminants and 
help control human infection. 
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Figure legends 
 
Figure 1. Effect of different concentrations of the antimicrobial on the three E. coli 
O157:H7 strains cell permeability as determined by measuring changes in relative 
electric conductivity.  Each point represents the mean ± standard deviation. MIC: 
minimum inhibitory concentration; MBC: minimum bactericidal concentration. 
 
Figure 2. Effect of different concentrations of the antimicrobial on the three E. coli 
O157:H7 strains protein (A) and nucleic acid release (B).  Each point represents the 
mean ± standard deviation. MIC: minimum inhibitory concentration; MBC: minimum 
bactericidal concentration. 
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Figure 3. Growth of E. coli O157:H7 EDL 933 (A), VSD 400 (B) and PHL 09 (C) in 
MHA with various concentrations of the antimicrobial. Each value represents the mean 
of three different measurements. 
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Figure 4. Levels of E. coli O157:H7 EDL 933 following treatment with different 
concentrations of the antimicrobial in an in vitro rumen system. Each point represents 
the mean ± standard deviation.   
 
Figure 5. Effect of different sub-inhibitory concentrations of the antimicrobial on 
biofilm formation of E. coli O157:H7 EDL 933. Each point represents the 
mean ± standard deviation.   
 
Figure 6. Effect of different sub-inhibitory concentrations of the antimicrobial on E. 
coli O157:H7 EDL 933 motility. Each point represents the mean ± standard deviation.  
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Figure 7. Quantitative determination of EPS inhibition E. coli O157:H7 EDL 933 after 
exposure to different sub-inhibitory concentrations of the antimicrobial. Each point 
represents the mean ± standard deviation. Results are expressed in percentages of 
the control treatment. 
 
Figure 8. Production of the autoinducer (AI-2) by E. coli O157:H7 EDL 933 after 
exposure to different sub-inhibitory concentrations of the antimicrobial (A). Levels 
of E. coli O157:H7 EDL 933 after exposure to different sub-inhibitory concentrations 
of the antimicrobial (B). Each point represents the mean ± standard deviation.  
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